Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

This study has been completed.

Study NCT00783081 Information provided by Kowa Research Institute, Inc.

First Received: October 30, 2008 Last Updated: March 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)

No publications provided by Kowa Research Institute, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials. 2011 May 25;12:134.